Genome Engineering Market to Reach US$7.21 bn by 2023, North America Held Dominant Share of 51.0% in 2014: Transparency Market Research

ALBANY, New York, February 18, 2016 /PRNewswire/ --

A new market research report has been recently published by Transparency Market Research (TMR), a U.S.-based market research and intelligence firm. According to the research study, the Genome Engineering Market was valued at US$2.20 bn in 2014 and is projected to expand at a CAGR of 14.2% from 2015 to 2023.

Genome engineering refers to the strategies and techniques implemented for the modification of target genetic information of any living organism. During the last few years, research spending has increased in gene editing technologies covering number of patents and research papers published exponentially. Synthetic biology received funding of US$ 430 Mn in the U.S. from 2005 to 2010, which was much higher than US$ 160 Mn in Europe during the same period. About 4% and 2% funding was spent on exploring ethical, social, and legal implications (ELSI) of synthetic biology in the U.S. and Europe, respectively.

Avail a Sample Research Study on Genome Engineering Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4671

Genome engineering technologies include Clustered regularly-interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), Zinc finger nuclease (ZFN) and other technologies, while the other technologies include antisense technology and recombinant AAV mediated genome engineering. Of these, CRISPR held the majority share of the market in 2014, followed by TALEN. CRISPR has been identified as the fastest growing segment during the forecast period, as it is cost-effective with high precision. CRISPR method is used for wide variety of disorders like sickle-cell anemia, HIV/AIDS, hemophilia and several forms of cancers. These techniques are in different stages of clinical development with a focus on modifying the genetic material of somatic cells.

Based on application, the cell line engineering segment accounted major share of the global genome engineering market in terms of revenue. Moreover, the segment is expected to gain market share and emerge as the fastest growing segment during the forecast period. Pharmaceutical and Biotechnology companies segment would grow as a fastest growing end-user segment with major share in the market.

Browse Report: http://www.transparencymarketresearch.com/genome-editing-engineering-market.html

High Demand from Pharmaceutical and Biotechnology Companies Bolsters Genome Engineering Market 

In terms of end user, the global genome engineering market is segmented into academics, pharmaceutical and biotechnology companies, and clinical research organizations (CRO). Among these, the largest share of the market was held by the pharmaceutical and biotechnology companies in 2014. The academics segment is expected to exhibit the fastest CAGR in the near future.

North America Emerges as Largest Regional Market 

Regionally, the global genome engineering market is spread across Asia Pacific, Europe, North America, and Rest of the World. Among these regions, North America held the largest share of the global genome engineering market in 2014, trailed by Europe. North American countries not only substantially contribute to the funding for genome research, but a majority of the key players are located in the U.S. Asia Pacific has emerged as the third-largest market for genome engineering; however, in the forthcoming years, the region is likely to exhibit the highest CAGR. Increase in funding for academic research spending will also boost the market in the near future.

Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Sangamo Biosciences, Inc., Lonza Group Ltd., Horizon Discovery Group Plc, Integrated DNA Technologies, Inc., Lonza Group Ltd., are the major players operating in the global Genome engineering market.

Browse Research Article: http://www.transparencymarketresearch.com/article/genome-editing-engineering-market.htm

The global Genome Engineering Market is segmented as follows: 

Global Genome Engineering Market, by Technology 

• Clustered regularly interspaced short palindromic repeats (CRISPR)
• Transcription activator-like effector nuclease (TALEN)
• Zinc Finger Nuclease (ZFN)
• Other Technologies

Global Genome Engineering Market, by Application 

• Overview
• Cell Line Engineering
• Animal Genome Engineering
• Plant Genome Engineering
• Other Application

Global Genome Engineering Market, by End-User 

• Overview
• Pharmaceutical and Biotechnology Companies
• Academics
• Clinical Research Organizations 

Other Trending Reports in Biotechnology: 

• Biotherapeutics Cell Line Development Market: http://www.transparencymarketresearch.com/biotherapeutics-cell-line-development-market.html

• Microbiology Culture Market: http://www.transparencymarketresearch.com/microbiology-culture-market.html

• Regenerative Medicine Market: http://www.transparencymarketresearch.com/regenerative-medicines-market.html

About Us:  

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:

Mr. Sudip.S
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/